To elucidate the prophylactic potential of anti-CD132 in T1D, we injected anti-CD132 or anti-IgG2b isotype control into nondiabetic NOD mice one day prior to cyclophosphamide injection (Fig. 7a). Here, IL2RG is linked to type 1 diabetes mellitus.